Azzad Asset Management Inc. ADV Invests $3.30 Million in Mettler-Toledo International Inc. (NYSE:MTD)

Azzad Asset Management Inc. ADV purchased a new stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,795 shares of the medical instruments supplier's stock, valued at approximately $3,301,000.

A number of other institutional investors have also modified their holdings of the company. Albert D Mason Inc. boosted its holdings in shares of Mettler-Toledo International by 3.4% in the 1st quarter. Albert D Mason Inc. now owns 1,255 shares of the medical instruments supplier's stock valued at $1,482,000 after buying an additional 41 shares in the last quarter. Simon Quick Advisors LLC boosted its holdings in shares of Mettler-Toledo International by 136.3% in the 1st quarter. Simon Quick Advisors LLC now owns 397 shares of the medical instruments supplier's stock valued at $469,000 after buying an additional 229 shares in the last quarter. CX Institutional bought a new stake in shares of Mettler-Toledo International in the 1st quarter valued at about $175,000. Assenagon Asset Management S.A. boosted its holdings in shares of Mettler-Toledo International by 43.4% in the 1st quarter. Assenagon Asset Management S.A. now owns 55,504 shares of the medical instruments supplier's stock valued at $65,545,000 after buying an additional 16,787 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Mettler-Toledo International by 11.2% in the 1st quarter. GAMMA Investing LLC now owns 327 shares of the medical instruments supplier's stock valued at $386,000 after buying an additional 33 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on MTD shares. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price target for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research note on Monday, April 7th. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Finally, Wells Fargo & Company lifted their target price on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $1,302.11.

Mettler-Toledo International Trading Down 2.9%

NYSE MTD traded down $34.56 on Friday, hitting $1,153.65. 109,215 shares of the company's stock traded hands, compared to its average volume of 151,706. Mettler-Toledo International Inc. has a 1-year low of $946.69 and a 1-year high of $1,546.93. The firm's 50-day moving average price is $1,105.54 and its two-hundred day moving average price is $1,204.23. The firm has a market capitalization of $23.98 billion, a PE ratio of 28.46, a P/E/G ratio of 3.30 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. During the same period in the previous year, the business posted $8.89 EPS. The business's quarterly revenue was down 4.6% compared to the same quarter last year. On average, research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director now directly owns 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.